跳至主要内容
临床试验/TCTR20200415001
TCTR20200415001已完成1 期

The Efficacy of Baclofen to Treat Gastroesophageal Reflux disease in Children Aged 6 Months to 12 Years

Golestan University of Medical Sciences0 个研究点目标入组 62 人开始时间: 2020年4月15日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
62

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 Months 至 12 Years(—)
性别
All

入选标准

  • all children aged 6 months to 12 years with GERD who had at least two of the following five symptoms for at least one month. These symptoms included vomiting immediately after feeding, the persistence of reflux symptoms despite other treatments, restlessness after feeding for one to three hours, apnea and respiratory distress after feeding, no weight gain or weight gain of less than 500 grams, or weight loss during the last month and refusal to feed

排除标准

  • patients less than 6 months and more than 12 years, patients taking baclofen for reasons other than GERD, patients with a history of anti-reflux surgery, patients with endoscopic evidence of Helicobacter pylori gastritis or eosinophilic esophagitis, patients with evidence of gastroparesis radiography and lack of parental consent to participate in the study

研究者

发起方
Golestan University of Medical Sciences

相似试验